United States · FDA National Drug Code directory
Stivarga
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-171_8f47fb28-9855-4482-b807-e98c425c2a4e
- Product NDC
- 50419-171
- Form
- TABLET, FILM COATED
- Composition / generic term
- regorafenib
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20120927
- Source listing expiry
- 20271231
Source-listed ingredients
- REGORAFENIB — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE · 50419-171-00
- 3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01) · 50419-171-03
- 1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC · 50419-171-04
- 4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05) · 50419-171-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →